These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 11240405

  • 1. [Doping: effectiveness, consequences, prevention].
    Guezennec CY.
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
    [Abstract] [Full Text] [Related]

  • 2. A race to the starting line.
    Vogel G.
    Science; 2004 Jul 30; 305(5684):632-5. PubMed ID: 15286358
    [No Abstract] [Full Text] [Related]

  • 3. [Doping and urologic tumors].
    Pinto F, Sacco E, Volpe A, Gardi M, Totaro A, Calarco A, Racioppi M, Gulino G, D'Addessi A, Bassi PF.
    Urologia; 2010 Jul 30; 77(2):92-9. PubMed ID: 20890867
    [Abstract] [Full Text] [Related]

  • 4. Analytical strategy for detecting doping agents in hair.
    Thieme D, Grosse J, Sachs H, Mueller RK.
    Forensic Sci Int; 2000 Jan 10; 107(1-3):335-45. PubMed ID: 10689585
    [Abstract] [Full Text] [Related]

  • 5. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM, Diallo B, Fall A, Ndiaye M, Cissè F, Faye B.
    Sante; 2005 Jan 10; 15(3):167-70. PubMed ID: 16207578
    [Abstract] [Full Text] [Related]

  • 6. [Doping--also a problem in general practice?].
    Dickhuth HH, Berg A, Baumstark M, Rokitzki L, Huonker M, Keul J.
    Fortschr Med; 1989 Sep 30; 107(28):585-8. PubMed ID: 2613151
    [Abstract] [Full Text] [Related]

  • 7. Introduction to the application of capillary gas chromatography of performance-enhancing drugs in doping control.
    Müller RK, Grosse J, Thieme D, Lang R, Teske J, Trauer H.
    J Chromatogr A; 1999 May 28; 843(1-2):275-85. PubMed ID: 10399856
    [Abstract] [Full Text] [Related]

  • 8. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop NM, Pigozzi F, Schänzer W, Vanhees L, ESC Study Group of Sports Cardiology.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 28; 13(5):687-94. PubMed ID: 17001206
    [Abstract] [Full Text] [Related]

  • 9. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M, Pipe A, Garnier PY, Vouillamoz M, Dvorak J.
    Br J Sports Med; 2014 May 28; 48(10):862-6. PubMed ID: 24648438
    [Abstract] [Full Text] [Related]

  • 10. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
    Tentori L, Graziani G.
    Pharmacol Res; 2007 May 28; 55(5):359-69. PubMed ID: 17349798
    [Abstract] [Full Text] [Related]

  • 11. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F, Mazzucco E, Gennaro MC, Marengo E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May 15; 927():22-36. PubMed ID: 23317577
    [Abstract] [Full Text] [Related]

  • 12. Doping in sport: effects, harm and misconceptions.
    Birzniece V.
    Intern Med J; 2015 Mar 15; 45(3):239-48. PubMed ID: 25369881
    [Abstract] [Full Text] [Related]

  • 13. Ergogenic drugs in sports.
    Knopp WD, Wang TW, Bach BR.
    Clin Sports Med; 1997 Jul 15; 16(3):375-92. PubMed ID: 9209817
    [Abstract] [Full Text] [Related]

  • 14. [Blood doping: 2].
    Cristani A, Boldrini E, Amateis E, Arioli D.
    Recenti Prog Med; 2005 Jan 15; 96(1):1-3. PubMed ID: 15789630
    [Abstract] [Full Text] [Related]

  • 15. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M, Kuuranne T, Geyer H.
    Drug Test Anal; 2019 Jan 15; 11(1):8-26. PubMed ID: 30488582
    [Abstract] [Full Text] [Related]

  • 16. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T, Kawabata T, Takayama A.
    Yakugaku Zasshi; 2017 Jan 15; 137(7):883-891. PubMed ID: 28674304
    [Abstract] [Full Text] [Related]

  • 17. [Medication, athletes and doping regulations].
    Hartgens F.
    Ned Tijdschr Geneeskd; 2008 Aug 16; 152(33):1844-8. PubMed ID: 18783164
    [Abstract] [Full Text] [Related]

  • 18. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M, Geyer H, Tretzel L, Schänzer W.
    J Pharm Biomed Anal; 2016 Oct 25; 130():220-230. PubMed ID: 27040951
    [Abstract] [Full Text] [Related]

  • 19. Medical aspects of drug use in the gym.
    Drug Ther Bull; 2004 Jan 25; 42(1):1-5. PubMed ID: 14768297
    [Abstract] [Full Text] [Related]

  • 20. Are drugs winning the games?
    Sullivan R, Song S.
    Time; 2000 Sep 11; 156(11):90-2. PubMed ID: 11067230
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.